These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23280061)

  • 1. The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel.
    Weil M; Shohat T; Bromberg M; Bassal R; Dichtiar R; Mandelboim M; Sofer D; Cohen D; Mendelson E
    Influenza Other Respir Viruses; 2013 Sep; 7(5):838-46. PubMed ID: 23280061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.
    Mörner A; Bråve A; Kling AM; Kühlmann-Berenzon S; Krook K; Hedenskog M; Silhammar I; Ljungman M; Ortqvist A; Andersson S; Brytting M; Thorstensson R; Linde A
    PLoS One; 2012; 7(12):e53511. PubMed ID: 23285299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-pandemic seroprevalence of 2009 pandemic influenza A (H1N1) virus in Shandong Province, China.
    Liu T; Li Z; Song S; Zhang S; Wang Y; Lin Y; Wang S; Wang X; Xu A; Bi Z
    Jpn J Infect Dis; 2012; 65(5):410-4. PubMed ID: 22996214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.
    Labato MI; Contrini MM; Lazzarini D; Campos AM; Gauna ML; Claros R; López EL; Savy VL; Luna CM
    Int J Infect Dis; 2014 Feb; 19():20-5. PubMed ID: 24211378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.
    Van Kerkhove MD; Hirve S; Koukounari A; Mounts AW;
    Influenza Other Respir Viruses; 2013 Sep; 7(5):872-86. PubMed ID: 23331969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
    PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.
    McVernon J; Laurie K; Faddy H; Irving D; Nolan T; Barr I; Kelso A
    Influenza Other Respir Viruses; 2014 Mar; 8(2):194-200. PubMed ID: 24382379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic.
    Reed C; Katz JM; Hancock K; Balish A; Fry AM;
    PLoS One; 2012; 7(10):e48187. PubMed ID: 23118949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in seroprevalence of antibodies to pandemic influenza H1N1 (2009) virus among patients seeking care in China.
    Xu C; Bai T; Wang M; Chen T; Wang L; Chen M; Zeng Y; Fan Ch; Yuan F; Shi J; Sun S; Li D; Wang S; Feng Z; Zhang Y; Yu H; Yang W; Wang Y; Shu Y
    Acta Virol; 2012; 56(4):329-35. PubMed ID: 23237089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplacental transfer efficiency of maternal antibodies against influenza A(H1N1)pdm09 virus and dynamics of naturally acquired antibodies in Chinese children: a longitudinal, paired mother-neonate cohort study.
    Li M; Wang W; Chen J; Zhan Z; Xu M; Liu N; Ren L; You L; Zheng W; Shi H; Zhao Z; Huang C; Chen X; Zheng N; Lu W; Zhou X; Zhou J; Liao Q; Yang J; Jit M; Salje H; Yu H
    Lancet Microbe; 2023 Nov; 4(11):e893-e902. PubMed ID: 37827184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.
    Jegaskanda S; Laurie KL; Amarasena TH; Winnall WR; Kramski M; De Rose R; Barr IG; Brooks AG; Reading PC; Kent SJ
    J Infect Dis; 2013 Oct; 208(7):1051-61. PubMed ID: 23812238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.
    Strengell M; Ikonen N; Ziegler T; Kantele A; Anttila VJ; Julkunen I
    Influenza Other Respir Viruses; 2013 May; 7(3):431-8. PubMed ID: 22913369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic.
    Bandaranayake D; Huang QS; Bissielo A; Wood T; Mackereth G; Baker MG; Beasley R; Reid S; Roberts S; Hope V;
    PLoS One; 2010 Oct; 5(10):e13211. PubMed ID: 20976224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.
    Gözalan A; Altaş AB; Sevencan F; Akın L; Korukluoğlu G; Kara S; Sevindi DF; Ertek M;
    Jpn J Infect Dis; 2012; 65(1):13-8. PubMed ID: 22274152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seroprevalence of pandemic influenza A (H1N1)pdm09 in two regions in Morocco following the 2010-2011 influenza season].
    El Rhaffouli H; El Boukhrissi F; Bajjou T; Laraqui A; Hilali F; Bahji M; El Harrak M; Lahlou Amine I
    Pathol Biol (Paris); 2013 Apr; 61(2):83-6. PubMed ID: 22728009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of Protective Antibodies Against Influenza and the Reduction of the Influenza Incidence Rate: An Annual Repeated Cross-Sectional Study From 2014 to 2019.
    Guiomar R; Pereira da Silva S; Costa I; Conde P; Cristóvão P; Rodrigues AP; Fernandes A; Dias AP; Couto AR; Ramos A; Moita C; Rodrigues C; Vale F; Caldeira F; Bruges Armas J; Pereira-Vaz J; Alves J; Freitas L; Martins L; Milho L; Mota-Vieira L; Lopes L; Freitas M; Pessanha MA; Correia M; Marques MH; Cardoso MJ; Peres MJ; Cunha M; Amantegui P; Mota P; Lopes P; Pereira P; Viseu R; Cabral R; Côrte-Real R; Almeida S; Soares V; Mansinho K; Hungnes O; Nunes B
    Influenza Other Respir Viruses; 2024 May; 18(5):e13307. PubMed ID: 38798072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.
    Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G
    Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.